Sponsored
Martin Kullen (VP, Human Health Science & Innovation) and Jakob Dalmose Rasmussen (VP, Strategy, Portfolio & Marketing) discuss how Novonesis distinguishes its probiotics on the market, and additionally cover the company’s in-house capabilities.